PRESS RELEASE published on 03/25/2026 at 13:20, 2 months 1 day ago Lobe Sciences Ltd. Reports Improved Financial Position and Strategic Update Lobe Sciences Ltd. significantly improves financial position: liabilities down 81%, cash up 24x, net working capital up $6.1M, outstanding warrants down 70%, and strengthened the balance sheet and capital structure Financial Position Balance Sheet Capital Structure Strategic Update Lobe Sciences Ltd.
BRIEF published on 03/09/2026 at 05:05, 2 months 18 days ago Lobe Sciences nomme Mirza Rahimani au poste de directeur financier Gouvernance D'Entreprise Biopharmaceutique Sciences Du Lobe Responsable Financier Mirza Rahimani
BRIEF published on 03/09/2026 at 05:05, 2 months 18 days ago Lobe Sciences Appoints Mirza Rahimani as CFO Corporate Governance Biopharmaceutical Financial Officer Lobe Sciences Mirza Rahimani
PRESS RELEASE published on 03/09/2026 at 05:00, 2 months 18 days ago Lobe Sciences Announces Appointment of Mr. Mirza Rahimani, CPA, CA as Chief Financial Officer Lobe Sciences Ltd. appoints Mirza Rahimani as Chief Financial Officer, leveraging his extensive finance experience. Learn more about the company's strategic developments and goals Chief Financial Officer Strategic Development Finance Lobe Sciences Ltd. Mirza Rahimani
BRIEF published on 03/05/2026 at 13:45, 2 months 21 days ago Lobe Sciences Ltd. annonce sa participation aux conférences sur les soins de santé à Miami Conférences Biopharmaceutique Soins De Santé Miami Programmes Thérapeutiques
BRIEF published on 03/05/2026 at 13:45, 2 months 21 days ago Lobe Sciences Ltd. Announces Participation at Miami Healthcare Conferences Healthcare Conférences Biopharmaceutical Miami Therapeutic Programs
PRESS RELEASE published on 03/05/2026 at 13:40, 2 months 21 days ago Lobe Sciences Ltd. Announces Presence in Miami During the Jefferies and Leerink Healthcare Conferences Lobe Sciences announces CEO availability for meetings during Jefferies and Leerink Healthcare Conferences in Miami. Company focuses on advancing therapeutic programs for medical needs Lobe Sciences Jefferies Conference Therapeutic Programs CEO Availability Leerink Healthcare Conference
BRIEF published on 02/03/2026 at 13:05, 3 months 23 days ago Lobe Sciences publie ses résultats financiers et ses initiatives pour le premier trimestre 2026 Investissement En R&D Développement De Médicaments Résumé Financier Sciences Du Lobe Résultats Du T1 2026
BRIEF published on 02/03/2026 at 13:05, 3 months 23 days ago Lobe Sciences Reports Q1 2026 Financial Results and Initiatives Drug Development R&D Investment Financial Summary Lobe Sciences Q1 2026 Results
PRESS RELEASE published on 02/03/2026 at 13:00, 3 months 23 days ago Lobe Sciences Reports First Quarter 2026 Results and Highlights Lobe Sciences Ltd. reports unaudited financial results for Q1:2026, with increased R&D activities and improved operating efficiency. The Company advances development programs in diseases with unmet medical needs Financial Results R&D Activities Operating Efficiency Medical Needs Lobe Sciences Ltd.
Published on 05/27/2026 at 02:10, 4 hours 10 minutes ago Western Investment Company Reports First Quarter 2026 Results and Announces Executive Personnel Changes
Published on 05/27/2026 at 01:45, 4 hours 35 minutes ago Organto Foods Announces Record First Quarter 2026 Financial Results
Published on 05/27/2026 at 00:25, 5 hours 55 minutes ago Revolve Reports Q3 F2026 Results Backed by Strong Progress Across North American Portfolio
Published on 05/26/2026 at 22:15, 8 hours 5 minutes ago LaFleur Announces Bought Deal Equity Offerings for Gross Proceeds of C$8 Million
Published on 05/26/2026 at 22:01, 8 hours 19 minutes ago Kidoz Inc. Reports Q1 2026 Financial Results with YoY Revenue Growth, Accelerating Strategic Investment in AI
Published on 05/27/2026 at 06:00, 20 minutes ago Verve Group Reports Solid Organic Growth in the First Quarter, Along with Strong Operating Performance and Significant Cash Flow Growth
Published on 05/26/2026 at 18:50, 11 hours 30 minutes ago The AI Gold Rush Is Running Into a Margin Problem
Published on 05/26/2026 at 18:30, 11 hours 50 minutes ago H2APEX publishes financial figures for the first quarter of 2026 and confirms forecast
Published on 05/26/2026 at 17:45, 12 hours 35 minutes ago FIGEAC AÉRO: EXTENSION DU PARTENARIAT AVEC UN CLIENT AMÉRICAIN
Published on 05/26/2026 at 17:30, 12 hours 50 minutes ago GEVELOT S.A.: Weekly declaration of share buybacks – 05/26/2026 (French only)
Published on 05/26/2026 at 18:39, 11 hours 40 minutes ago Déclaration des opérations d'achats d'actions réalisées le 18 mai 2026
Published on 05/26/2026 at 18:39, 11 hours 40 minutes ago Reporting on share buyback transactions carried out on May 18, 2026
Published on 05/26/2026 at 17:45, 12 hours 35 minutes ago EURAZEO INVESTS IN BABYLON, A FRENCH OPERATOR OF NEXT-GENERATION APARTHOTELS
Published on 05/26/2026 at 17:45, 12 hours 35 minutes ago EURAZEO INVESTIT DANS BABYLON, SPÉCIALISTE FRANÇAIS DES APARTHOTELS DE NOUVELLE GÉNÉRATION
Published on 05/26/2026 at 17:40, 12 hours 40 minutes ago LDC : Nombre total de droits de vote et d'actions composant le capital au 30.04.26.